#immuneengineering search results

Excited for our upcoming #ImmuneEngineering issue @ Adv Drug Delivery Rev., edited by me & K.Roy. Must read rev. from leaders in field! 1/23

Dr_ASingh's tweet image. Excited for our upcoming #ImmuneEngineering issue @ Adv Drug Delivery Rev., edited by me & K.Roy. Must read rev. from leaders in field! 1/23

#ImmuneEngineering (14/23): J Elisseeff et al "Key players in #immune response to scaffolds for #regenerative med." sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (14/23): J Elisseeff et al  "Key players in #immune response to scaffolds for #regenerative med." sciencedirect.com/science/articl…

#ImmuneEngineering (15/23): J Collier et al @Duke discuss biomaterials for generating therapeutic immune responses sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (15/23): J Collier et al @Duke discuss biomaterials for generating therapeutic immune responses  sciencedirect.com/science/articl…

#ImmuneEngineering (6/23):Phelps/Baekkeskov/Hubbell "BioE strategies for inducing tolerance in #autoimmune diabetes" sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (6/23):Phelps/Baekkeskov/Hubbell "BioE strategies for inducing tolerance in #autoimmune diabetes" sciencedirect.com/science/articl…

#ImmuneEngineering (13/23): Lonnie Shea et al "In vivo reprogramming of immune cells for antigen-specific tolerance" sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (13/23): Lonnie Shea et al "In vivo reprogramming of immune cells for antigen-specific tolerance" sciencedirect.com/science/articl…

#ImmuneEngineering (12/23): We discuss drug discov., #epigenetics, PDX, & therapeutic delivery for #lymphoid #tumors sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (12/23): We discuss drug discov., #epigenetics, PDX, & therapeutic delivery for #lymphoid #tumors sciencedirect.com/science/articl…

After the Kolloquium is before the Kolloquium: Safe the date for our 74th #MosbacherKolloquium 2023 on the topic “#ImmuneEngineering – from Molecules to Therapeutic Approaches”, March 23-25, 2023! More information will follow in due time.

GBM_eV's tweet image. After the Kolloquium is before the Kolloquium: Safe the date for our 74th #MosbacherKolloquium 2023 on the topic “#ImmuneEngineering – from Molecules to Therapeutic Approaches”, March 23-25, 2023! More information will follow in due time.

We have an active search for tenure-track faculty interested in #ImmuneEngineering #ProteinEngineering #GenomeEngineering & #CancerImmunology. Join the newly formed Center for Cellular Therapies and Cancer Immunology #CCTCI. Learn more at apply.interfolio.com/173562. #facultyjobs

jaehyukchoimd's tweet image. We have an active search for tenure-track faculty interested in #ImmuneEngineering #ProteinEngineering #GenomeEngineering & #CancerImmunology. Join the newly formed Center for Cellular Therapies and Cancer Immunology #CCTCI. Learn more at apply.interfolio.com/173562. #facultyjobs

Inspiring fireside chat @UDelaware w/@NIHDirector & @ChrisCoons highlighting needs for #vaccines #personalizedmed #immuneEngineering & #SCALEUP (sounds like opportunities for @UDengineering @UDChBE @udbme to me!)

cfromen's tweet image. Inspiring fireside chat @UDelaware w/@NIHDirector & @ChrisCoons highlighting needs for #vaccines #personalizedmed  #immuneEngineering & #SCALEUP (sounds like opportunities for @UDengineering @UDChBE @udbme to me!)

The @JuniorGBM has reached a remarkable size🤩! Thank you all for your participation, thank you for a great Mosbacher Kolloquium, fantastic talks and many excellent conversations. We are already looking forward to 2023, when the topic will be #ImmuneEngineering.

GBM_eV's tweet image. The @JuniorGBM has reached a remarkable size🤩! Thank you all for your participation, thank you for a great Mosbacher Kolloquium, fantastic talks and many excellent conversations. We are already looking forward to 2023, when the topic will be #ImmuneEngineering.
GBM_eV's tweet image. The @JuniorGBM has reached a remarkable size🤩! Thank you all for your participation, thank you for a great Mosbacher Kolloquium, fantastic talks and many excellent conversations. We are already looking forward to 2023, when the topic will be #ImmuneEngineering.

#ImmuneEngineering (16/23): @KrishRoyLab describe cells as "drugs": biomanufacturing of cell-based #immunotherapies sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (16/23): @KrishRoyLab describe cells as "drugs": biomanufacturing  of cell-based #immunotherapies sciencedirect.com/science/articl…

⁦⁦@JuniorGBM⁩ Leipzig at #ImmuneEngineering in Ulm! Clara and Paul, great to see you and thanks for coming 👍🏻😊

GBM_eV's tweet image. ⁦⁦@JuniorGBM⁩ Leipzig at #ImmuneEngineering in Ulm! Clara and Paul, great to see you and thanks for coming 👍🏻😊

📢74th Mosbacher Kolloquium - “#ImmuneEngineering - From Molecules to Therapeutic Approaches”, March 23-25! 📆Deadline abstract submission: Jan 31 📆Deadline Early Bird registration: Jan 31 📆Deadline travel allowance application for young GBM members: Feb 15 Register now! 👇

GBM_eV's tweet image. 📢74th Mosbacher Kolloquium - “#ImmuneEngineering - From Molecules to Therapeutic Approaches”, March 23-25! 
📆Deadline abstract submission: Jan 31
📆Deadline Early Bird registration: Jan 31
📆Deadline travel allowance application for young GBM members: Feb 15
Register now! 👇

Simona Plesselova, delaPuente lab Postdoctoral Fellow, rocked her oral presentation today #BMES2022 Proud of her hard work! #immuneengineering #hypoxia #ovariancancer

delapuente_lab's tweet image. Simona Plesselova, delaPuente lab Postdoctoral Fellow, rocked her oral presentation today #BMES2022 Proud of her hard work! #immuneengineering #hypoxia #ovariancancer
delapuente_lab's tweet image. Simona Plesselova, delaPuente lab Postdoctoral Fellow, rocked her oral presentation today #BMES2022 Proud of her hard work! #immuneengineering #hypoxia #ovariancancer

#ImmuneEngineering (10/23): Ravi Bellamkonda et al discuss "Engineering challenges for #brain #tumor #immunotherapy" sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (10/23): Ravi Bellamkonda et al discuss "Engineering challenges for #brain #tumor #immunotherapy" sciencedirect.com/science/articl…

The National Academy of Medicine has named @UTBiomedical's Dr. @JennyNJiang one of 10 emerging leaders in health and medicine. #ImmuneEngineering #TexasEngineer #WhatStartsHereChangesTheWorld engr.utexas.edu/news/archive/8…

UTBiomedical's tweet image. The National Academy of Medicine has named @UTBiomedical's Dr. @JennyNJiang one of 10 emerging leaders in health and medicine. #ImmuneEngineering #TexasEngineer #WhatStartsHereChangesTheWorld engr.utexas.edu/news/archive/8…

We have an active search for tenure-track faculty interested in #ImmuneEngineering #ProteinEngineering #GenomeEngineering & #CancerImmunology. Join the newly formed Center for Cellular Therapies and Cancer Immunology #CCTCI. Learn more at apply.interfolio.com/173562. #facultyjobs


We have an active search for tenure-track faculty interested in #ImmuneEngineering #ProteinEngineering #GenomeEngineering & #CancerImmunology. Join the newly formed Center for Cellular Therapies and Cancer Immunology #CCTCI. Learn more at apply.interfolio.com/173562. #facultyjobs

jaehyukchoimd's tweet image. We have an active search for tenure-track faculty interested in #ImmuneEngineering #ProteinEngineering #GenomeEngineering & #CancerImmunology. Join the newly formed Center for Cellular Therapies and Cancer Immunology #CCTCI. Learn more at apply.interfolio.com/173562. #facultyjobs

🧬 Boosting cancer immunotherapy with synthetic immunity! A smart, self-healing hydrogel embeds extracellular vesicles to form artificial lymphoid structures and supercharge immune checkpoint blockade. Hashtags: #CancerImmunotherapy #ImmuneEngineering doi.org/10.1016/j.biom…


What if we could reprogram our immune system to fight any disease? - #ImmuneEngineering #DiseaseResistance #HealthInnovation #Biotech


Incredibly proud of our brave trainees @AThumsi @spihba Dr. Jaggarapu, Taravat Khodaei, for moving and setting up our #immuneEngineering #immunometabolism lab @cwru @CWRUBME !! Looking forward to new collaborations, research in #neuroimmuneEngineering case.edu/engineering/la…


Wyss researchers developed a novel tunable biomaterial system that allows them to investigate and leverage the effects of tissue mechanics on the state of therapeutic T cells in vitro. #ImmuneEngineering #Immunotherapy wyss.harvard.edu/technology/tun…


⁦⁦@JuniorGBM⁩ Leipzig at #ImmuneEngineering in Ulm! Clara and Paul, great to see you and thanks for coming 👍🏻😊

GBM_eV's tweet image. ⁦⁦@JuniorGBM⁩ Leipzig at #ImmuneEngineering in Ulm! Clara and Paul, great to see you and thanks for coming 👍🏻😊

Uwe Bücheler @BoehringerDE is opening our joint event on #ImmuneEngineering in Ulm with @BioPharmaCL_GER! Looking forward to a fantastic meeting with great talks and new insights 👍🏻

GBM_eV's tweet image. Uwe Bücheler @BoehringerDE is opening our joint event on #ImmuneEngineering in Ulm with @BioPharmaCL_GER! Looking forward to a fantastic meeting with great talks and new insights 👍🏻

Exciting News! Join us for the Immune Engineering SIG's webinar featuring talks from their 2023 Poster Awardees. 🏆 Don't miss three great research presentations on December 6th at 12 PM ET. Mark your calendars! 🗓️ bit.ly/3Fy3IuU @SFBImmuneEng #ImmuneEngineering

SFBiomaterials's tweet image. Exciting News! Join us for the Immune Engineering SIG's webinar featuring talks from their 2023 Poster Awardees. 🏆 Don't miss three great research presentations on December 6th at 12 PM ET. Mark your calendars! 🗓️ bit.ly/3Fy3IuU @SFBImmuneEng #ImmuneEngineering

📢FREE OF CHARGE (☝️but registration required☝️) On Dec 1 we will meet in Ulm for a half day of lectures and a panel discussion on #ImmuneEngineering, details at immune-engineering.gbm-online.de 👉Join @GBM_eV and @BioPharmaCL_GER for a great event with plenty of networking opportunities!

GBM_eV's tweet image. 📢FREE OF CHARGE (☝️but registration required☝️) On Dec 1 we will meet in Ulm for a half day of lectures and a panel discussion on #ImmuneEngineering, details at immune-engineering.gbm-online.de
👉Join @GBM_eV and @BioPharmaCL_GER for a great event with plenty of networking opportunities!

📢Take the chance, registration is free of charge! Join @GBM_eV and @BioPharmaCL_GER on December 1 in Ulm, focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking, details at immune-engineering.gbm-online.de – See you in Ulm!

GBM_eV's tweet image. 📢Take the chance, registration is free of charge! Join @GBM_eV and @BioPharmaCL_GER on December 1 in Ulm, focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking, details at immune-engineering.gbm-online.de – See you in Ulm!

Registration open! @GBM_eV and @BioPharmaCL_GER teamed up for their 2nd joint event on Dec 1: focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking – Participation free of charge, but places are limited

GBM_eV's tweet image. Registration open! @GBM_eV  and @BioPharmaCL_GER teamed up for their 2nd joint event on Dec 1: focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking – Participation free of charge, but places are limited

"Immune Engineering - from Molecules to Therapeutic Approaches" Interested? Safe the date: 01.12.2023 Registration opens: 04.10.2023 We would love to welcome you in Ulm! #GBM #ImmuneEngineering #BPCluster #Research #ClinicalResearch #Immunology

📢Save the date: GBM and @BioPharmaCL_GER teamed up for their 2nd joint event on Dec 1: focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking – Participation free of charge, but places are limited, registration will open on October 4th 👇

GBM_eV's tweet image. 📢Save the date: GBM and @BioPharmaCL_GER teamed up for their 2nd joint event on Dec 1: focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking – Participation free of charge, but places are limited, registration will open on October 4th 👇


📢Save the date: GBM and @BioPharmaCL_GER teamed up for their 2nd joint event on Dec 1: focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking – Participation free of charge, but places are limited, registration will open on October 4th 👇

GBM_eV's tweet image. 📢Save the date: GBM and @BioPharmaCL_GER teamed up for their 2nd joint event on Dec 1: focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking – Participation free of charge, but places are limited, registration will open on October 4th 👇

ADDR open access: Aerosol Pulmonary Immune Engineering. By Catherine A. Fromen & coworkers @cfromen @UDChBE #aerosol #pulmonarydelivery #ImmuneEngineering doi.org/10.1016/j.addr…


OBS #Immunology Seminar 📆 Thursday, May 25, 7 am PT / 10 am ET / 4 pm CEST/10 pm HKT MODERATOR HIGHLIGHT 🎤 @kurianlab @UKkoeln 👉 Register: us02web.zoom.us/meeting/regist… #Immuneengineering #OpenScience

OpenBoxSci's tweet image. OBS #Immunology Seminar 
📆 Thursday, May 25, 7 am PT / 10 am ET / 4 pm CEST/10 pm HKT 

MODERATOR HIGHLIGHT
🎤 @kurianlab @UKkoeln

👉 Register: us02web.zoom.us/meeting/regist… 

#Immuneengineering 
#OpenScience

Come join #ImmuneEngineering SIG @SFB !!

Interested in a great leadership opportunity? SFB is looking for SIG Officers for the 2023-2025 term. Learn more & submit your nomination for Chair, Vice Chair, Secretary/Treasurer, or Program Chair by 5/1! (membership must be current) bit.ly/3zoai4c



📢Last chance for a reduced conference fee: Register online until March 8 at mosbacher-kolloquium.org and join us for #ImmuneEngineering - from Molecules to Therapeutic Approaches 🤩

📢Registration deadline for our #MosbacherKolloquium is March 8! 👉Register today at mosbacher-kolloquium.org and be part of a great conference on #ImmuneEngineering. CU in Mosbach 🤩

GBM_eV's tweet image. 📢Registration deadline for our #MosbacherKolloquium is March 8! 👉Register today at mosbacher-kolloquium.org and be part of a great conference on #ImmuneEngineering. CU in Mosbach 🤩


📢Registration deadline for our #MosbacherKolloquium is March 8! 👉Register today at mosbacher-kolloquium.org and be part of a great conference on #ImmuneEngineering. CU in Mosbach 🤩

GBM_eV's tweet image. 📢Registration deadline for our #MosbacherKolloquium is March 8! 👉Register today at mosbacher-kolloquium.org and be part of a great conference on #ImmuneEngineering. CU in Mosbach 🤩

No results for "#immuneengineering"

Excited for our upcoming #ImmuneEngineering issue @ Adv Drug Delivery Rev., edited by me & K.Roy. Must read rev. from leaders in field! 1/23

Dr_ASingh's tweet image. Excited for our upcoming #ImmuneEngineering issue @ Adv Drug Delivery Rev., edited by me & K.Roy. Must read rev. from leaders in field! 1/23

#ImmuneEngineering (14/23): J Elisseeff et al "Key players in #immune response to scaffolds for #regenerative med." sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (14/23): J Elisseeff et al  "Key players in #immune response to scaffolds for #regenerative med." sciencedirect.com/science/articl…

#ImmuneEngineering (12/23): We discuss drug discov., #epigenetics, PDX, & therapeutic delivery for #lymphoid #tumors sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (12/23): We discuss drug discov., #epigenetics, PDX, & therapeutic delivery for #lymphoid #tumors sciencedirect.com/science/articl…

OBS #Immunology Seminar 📆 Thursday, May 25, 7 am PT / 10 am ET / 4 pm CEST/10 pm HKT MODERATOR HIGHLIGHT 🎤 @kurianlab @UKkoeln 👉 Register: us02web.zoom.us/meeting/regist… #Immuneengineering #OpenScience

OpenBoxSci's tweet image. OBS #Immunology Seminar 
📆 Thursday, May 25, 7 am PT / 10 am ET / 4 pm CEST/10 pm HKT 

MODERATOR HIGHLIGHT
🎤 @kurianlab @UKkoeln

👉 Register: us02web.zoom.us/meeting/regist… 

#Immuneengineering 
#OpenScience

#ImmuneEngineering (6/23):Phelps/Baekkeskov/Hubbell "BioE strategies for inducing tolerance in #autoimmune diabetes" sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (6/23):Phelps/Baekkeskov/Hubbell "BioE strategies for inducing tolerance in #autoimmune diabetes" sciencedirect.com/science/articl…

#ImmuneEngineering (15/23): J Collier et al @Duke discuss biomaterials for generating therapeutic immune responses sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (15/23): J Collier et al @Duke discuss biomaterials for generating therapeutic immune responses  sciencedirect.com/science/articl…

The @JuniorGBM has reached a remarkable size🤩! Thank you all for your participation, thank you for a great Mosbacher Kolloquium, fantastic talks and many excellent conversations. We are already looking forward to 2023, when the topic will be #ImmuneEngineering.

GBM_eV's tweet image. The @JuniorGBM has reached a remarkable size🤩! Thank you all for your participation, thank you for a great Mosbacher Kolloquium, fantastic talks and many excellent conversations. We are already looking forward to 2023, when the topic will be #ImmuneEngineering.
GBM_eV's tweet image. The @JuniorGBM has reached a remarkable size🤩! Thank you all for your participation, thank you for a great Mosbacher Kolloquium, fantastic talks and many excellent conversations. We are already looking forward to 2023, when the topic will be #ImmuneEngineering.

After the Kolloquium is before the Kolloquium: Safe the date for our 74th #MosbacherKolloquium 2023 on the topic “#ImmuneEngineering – from Molecules to Therapeutic Approaches”, March 23-25, 2023! More information will follow in due time.

GBM_eV's tweet image. After the Kolloquium is before the Kolloquium: Safe the date for our 74th #MosbacherKolloquium 2023 on the topic “#ImmuneEngineering – from Molecules to Therapeutic Approaches”, March 23-25, 2023! More information will follow in due time.

#ImmuneEngineering (13/23): Lonnie Shea et al "In vivo reprogramming of immune cells for antigen-specific tolerance" sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (13/23): Lonnie Shea et al "In vivo reprogramming of immune cells for antigen-specific tolerance" sciencedirect.com/science/articl…

The National Academy of Medicine has named @UTBiomedical's Dr. @JennyNJiang one of 10 emerging leaders in health and medicine. #ImmuneEngineering #TexasEngineer #WhatStartsHereChangesTheWorld engr.utexas.edu/news/archive/8…

UTBiomedical's tweet image. The National Academy of Medicine has named @UTBiomedical's Dr. @JennyNJiang one of 10 emerging leaders in health and medicine. #ImmuneEngineering #TexasEngineer #WhatStartsHereChangesTheWorld engr.utexas.edu/news/archive/8…

#ImmuneEngineering (16/23): @KrishRoyLab describe cells as "drugs": biomanufacturing of cell-based #immunotherapies sciencedirect.com/science/articl…

Dr_ASingh's tweet image. #ImmuneEngineering (16/23): @KrishRoyLab describe cells as "drugs": biomanufacturing  of cell-based #immunotherapies sciencedirect.com/science/articl…

Inspiring fireside chat @UDelaware w/@NIHDirector & @ChrisCoons highlighting needs for #vaccines #personalizedmed #immuneEngineering & #SCALEUP (sounds like opportunities for @UDengineering @UDChBE @udbme to me!)

cfromen's tweet image. Inspiring fireside chat @UDelaware w/@NIHDirector & @ChrisCoons highlighting needs for #vaccines #personalizedmed  #immuneEngineering & #SCALEUP (sounds like opportunities for @UDengineering @UDChBE @udbme to me!)

⁦⁦@JuniorGBM⁩ Leipzig at #ImmuneEngineering in Ulm! Clara and Paul, great to see you and thanks for coming 👍🏻😊

GBM_eV's tweet image. ⁦⁦@JuniorGBM⁩ Leipzig at #ImmuneEngineering in Ulm! Clara and Paul, great to see you and thanks for coming 👍🏻😊

Simona Plesselova, delaPuente lab Postdoctoral Fellow, rocked her oral presentation today #BMES2022 Proud of her hard work! #immuneengineering #hypoxia #ovariancancer

delapuente_lab's tweet image. Simona Plesselova, delaPuente lab Postdoctoral Fellow, rocked her oral presentation today #BMES2022 Proud of her hard work! #immuneengineering #hypoxia #ovariancancer
delapuente_lab's tweet image. Simona Plesselova, delaPuente lab Postdoctoral Fellow, rocked her oral presentation today #BMES2022 Proud of her hard work! #immuneengineering #hypoxia #ovariancancer

Registration open! @GBM_eV and @BioPharmaCL_GER teamed up for their 2nd joint event on Dec 1: focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking – Participation free of charge, but places are limited

GBM_eV's tweet image. Registration open! @GBM_eV  and @BioPharmaCL_GER teamed up for their 2nd joint event on Dec 1: focus on translational research in #ImmuneEngineering, lectures, panel discussion, networking – Participation free of charge, but places are limited

On Tuesday, March 2, Drs. Kaitlyn Sadtler and Krishnendu Roy will present a webinar entitled "Analysis of Human Immunity to SARS-CoV-2" at 4 PM EST. Register Here - bit.ly/2NhYcEW @KSadtler @KrishRoyLab #biomaterials #immuneengineering #covid19

SFBiomaterials's tweet image. On Tuesday, March 2, Drs. Kaitlyn Sadtler and Krishnendu Roy will present a
webinar entitled "Analysis of Human Immunity to SARS-CoV-2" at 4 PM EST. Register Here - bit.ly/2NhYcEW @KSadtler @KrishRoyLab #biomaterials #immuneengineering #covid19

Loading...

Something went wrong.


Something went wrong.


United States Trends